- Cancer Biology & Biomarkers
- Chromatography & Mass Spectrometry
- Contract Research, Clinical Trials and Outsourcing
- Drug Discovery
- Drug Targets
- Flow Cytometry
- Informatics & Lab Automation
- Ingredients, Excipients and Dosages
- Microbiology & RMMs
- NIR, PAT & QbD
- Raman Spectroscopy
- Screening, Assays & High-Content Analysis
- Thermal Processing
- Events & Workshops
PerkinElmer Inc. - Articles and news items
Whitepapers / 2 January 2017 / PerkinElmer
he U.S. Pharmocopeia is in the process of revising the analytical protocols for the analysis of metals in pharmaceutical products. A detailed summary of the methodology and the changes is available, so only a brief description will be given here…
With the huge range of processes involved in drug discovery and manufacture, it’s no wonder we had to create a separate magazine for this content – and as such we have a wide variety of applications…
Supplier news / 2 September 2016 / PerkinElmer Inc
ChemDraw software moves to the cloud for enhanced collaboration among chemists and biologists…
Supplier news / 18 February 2016 / PerkinElmer Inc
New data discovery solution leverages Attivio’s platform to provide insight into complex scientific challenges…
New approaches to cell based assays for high content screening and analysis.
Reduce, reuse, recycle: how drug repositioning is finding its niche in drug discovery.
Workshop Review: Biochemical assays for screening.
Videos / 28 July 2013 / PerkinElmer Inc.
In this video interview, Dr. Chris Bakal from the Institute of Cancer Research, London, describes how his research group studies the shape changes of metastatic cells and how they spread through the body to cause disease. He explains how scientists perform high throughput RNA interference screens using the Opera® High Content Screening System, imaging millions of cells and quantifying individual shapes using a phenotypic approach…
Revolutionaries for Global Health Summit, 5 -6 March 2013, Brussels
Issue 1 2013 / 21 February 2013 / Sheraz Gul, Head of Biology at European ScreeningPort, Hamburg, Germany
Recent years have witnessed an expansion in the disciplines encompassing drug discovery outside the pharmaceutical industry. This is most notable with a significant number of universities worldwide that now host infrastructure such as compound libraries and automated screening centres[1-3]. An archetypal small molecule drug discovery project will aim to identify chemical starting points that modify the functions of genes, cells or biochemical pathways. In some, but not all instances, these functions may be linked to disease processes, and an opportunity will exist to further develop the probes into novel therapeutic agents. In small molecule drug discovery, the ultimate aim is to identify new therapeutics, an activity which for reasons of high risk and cost has historically been conducted within the commercial sectors.
PerkinElmer, Inc., has unveiled its OneSource® Scientific IT Services…
PerkinElmer, Inc. has signed a definitive agreement to acquire Caliper Life Sciences, Inc…
First to combine optical label-free technology & traditional labeled assays to accurately identify potential new therapeutic targets…
PerkinElmer, Inc., announced the introduction of a new GMP* compliant radiochemical solution, Lu-177 nuclide…
ABB Analytical Measurement ACD/Labs ADInstruments Ltd Advanced Analytical Technologies GmbH Analytik Jena AG Astell Scientific Ltd B&W Tek Bachem AG Bibby Scientific Limited Bio-Rad Laboratories BioNavis Ltd Biopharma Group Black Swan Analysis Limited Charles Ischi AG | Kraemer Elektronik Cherwell Laboratories CI Precision Cobalt Light Systems Coulter Partners CPC Biotech srl Dassault Systèmes BIOVIA DiscoverX Edinburgh Instruments Enterprise System Partners (ESP) EUROGENTEC F.P.S. Food and Pharma Systems Srl IDBS JEOL Europe L.B. Bohle Maschinen + Verfahren GmbH Lab M Ltd. LabWare Linkam Scientific Instruments Limited Molins Technologies Multicore Dynamics Ltd Nanosurf New England Biolabs, Inc. Panasonic Biomedical Sales Europe B.V. PerkinElmer Inc ReAgent Russell Finex Limited Source BioScience Takara Clontech Tornado Spectral Systems Tuttnauer Watson-Marlow Fluid Technology Group Wickham Laboratories Limited Xylem Analytics YMC Europe GmbH Yusen Logistics